Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.

We have previously reported on the analysis of TP53 coding mutations in 12 classic Li-Fraumeni syndrome (LFS) families plus 9 families that were Li-Fraumeni-like (LFL) families (J. M. Birch et al., Cancer Res., 54: 1298-1304, 1994). Mutations were found in 6 of 12 LFS families and in 1 of 9 LFL families. We have now extended these studies to include an additional nine LFS and nine LFL families, and TP53 mutations have been detected in eight of nine LFS families and in three of nine LFL families. Six of the new mutations described here are the same as those previously identified in other Li-Fraumeni families and are missense mutations at codons 245, 248, and 273 (in two families); a nonsense mutation at codon 209; and a mutation at the splice donor site in exon 4. The other five mutations are novel germ-line mutations and include missense mutations at codons 136 and 344, a 2-bp deletion within codon 191, a splice acceptor mutation in intron 3, and a 167-bp deletion of part of exon 1 and intron 1. In addition, we have detected a codon 175 mutation in a family previously reported as TP53 negative. To summarize all of the data from the families we have studied in this and our previous report (J. M. Birch et al., Cancer Res., 54: 1298-1304, 1994), mutations have been detected in 15 of 21 LFS families (71%) and in 4 of 18 LFL families (22%). These figures are somewhat higher than those previously reported by us and others for the frequency of TP53 mutations in LFS and LFL families. This could reflect our analysis of all 11 exons of TP53, including noncoding regions, as well as the use of direct sequencing rather than other less-sensitive mutation detection methods.

[1]  G. Thomas,et al.  Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. , 1993, Oncogene.

[2]  S. Friend,et al.  A functional screen for germ line p53 mutations based on transcriptional activation. , 1992, Cancer research.

[3]  M. Prados,et al.  Constitutional p53 mutations associated with brain tumors in young adults. , 1995, Cancer genetics and cytogenetics.

[4]  E. Shaulian,et al.  Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation. , 1993, The EMBO journal.

[5]  D. Evans,et al.  A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome. , 1996, Oncogene.

[6]  R. Ueda,et al.  Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. , 1994, Oncogene.

[7]  C. Harris,et al.  Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model. , 1996, Cancer research.

[8]  A. Craft,et al.  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. , 1994, Cancer research.

[9]  Erwin G. Van Meir,et al.  A simple p 53 functional assay for screening cell lines , blood , and tumors ( tumor-suppressor gene / Li-Fraumeni syndrome / transcription factor / mutation detection / ADE 2 gene ) , 2022 .

[10]  J. Varley,et al.  Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family , 1997, Oncogene.

[11]  R. McLendon,et al.  Alterations of the TP53 gene in human gliomas. , 1994, Cancer research.

[12]  J. Barrett,et al.  An Alu polymorphism intragenic to the TP53 gene. , 1991, Nucleic acids research.

[13]  R. Reddel,et al.  Germ-line splicing mutation of the p53 gene in a cancer-prone family. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  D. Evans,et al.  An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. , 1995, Journal of medical genetics.

[15]  J. Weissenbach,et al.  Allelic imbalance on chromosome I in human breast cancer. II. Microsatellite repeat analysis , 1995, Genes, chromosomes & cancer.

[16]  C. Portwine,et al.  High frequency of germline p53 mutations in childhood adrenocortical cancer. , 1994, Journal of the National Cancer Institute.

[17]  A T Look,et al.  Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. , 1994, Oncogene.

[18]  S. Friend,et al.  Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. , 1995, Oncogene.

[19]  S. Steinberg,et al.  p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. , 1992, Oncogene.

[20]  R. Weichselbaum,et al.  Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. , 1992, The New England journal of medicine.

[21]  L. Bobrow,et al.  Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining. , 1995, Journal of medical genetics.

[22]  S. Friend,et al.  Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. , 1997, The New England journal of medicine.

[23]  Thierry Soussi,et al.  Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation , 1996, Nucleic Acids Res..

[24]  R Montesano,et al.  Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.

[25]  A. Gottlieb,et al.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. , 1995, The Journal of clinical investigation.

[26]  D. Evans,et al.  A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier. , 1996, Cancer genetics and cytogenetics.

[27]  R. Hruban,et al.  p 53 Mutations in Pancreatic Carcinoma and Evidence of Common Involvement of Homocopolymer Tracts in DNA Microdeletions 1 , 2006 .

[28]  S. Friend,et al.  Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma , 1992 .

[29]  B. Vogelstein,et al.  Inherited p53 gene mutations in breast cancer. , 1992, Cancer research.

[30]  H. B. Marsden,et al.  Are germ cell tumors part of the Li-Fraumeni cancer family syndrome? , 1989, Cancer genetics and cytogenetics.

[31]  Y. Takeshima,et al.  p53 mutations in lung cancers from non-smoking atomic-bomb survivors , 1993, The Lancet.

[32]  P. Kleihues,et al.  Familial Brain Tumour Syndrome Associated with a p53 Germline Deletion of Codon 236 , 1995, Brain pathology.

[33]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[34]  D. Lane,et al.  Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. , 1994, British Journal of Cancer.

[35]  N. Pavletich,et al.  Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms , 1995, Science.

[36]  C. Bonaïti‐pellié,et al.  Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. , 1993, Cancer research.

[37]  A. Craft,et al.  p53 germline mutations in Li-Fraumeni syndrome , 1991, The Lancet.

[38]  J. Yokota,et al.  Germ-line p53 mutation is uncommon in patients with triple primary cancers. , 1993, Cancer letters.

[39]  Y. Nakamura,et al.  Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism , 1992, Genes, chromosomes & cancer.

[40]  C. Felix,et al.  A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. , 1993, Oncogene.

[41]  W. Blattner,et al.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.

[42]  J. Yokota,et al.  Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. , 1992, Journal of the National Cancer Institute.

[43]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.